Target Name: MIR4642
NCBI ID: G100616352
Other Name(s): microRNA 4642 | hsa-miR-4642 | hsa-mir-4642 | MicroRNA 4642

MIR4642: A Potential Drug Target and Biomarker for Obesity

Obesity has become a significant public health issue in recent years, with approximately 20% of adults in the United States having obesity. This not only affects physical health but also has a significant impact on mental health and overall quality of life. The obesity epidemic is projected to continue to worsen, with a projected increase in obesity rates to 35% by 2030. Therefore, identifying potential drug targets and biomarkers for obesity is crucial for developing effective treatments. One potential drug target and biomarker that has gained attention in recent years is MIR4642.

MIR4642 is a non-coding RNA molecule that has been identified as a potential drug target for obesity. It is located in the oblong cluster of genes (OBG) and is known as the MIR4642 gene. MIR4642 has been shown to play a role in the regulation of energy metabolism and can influence body weight and obesity.

Recent studies have demonstrated that MIR4642 is highly expressed in human obese tissues, including fat tissue, and is downregulated in human lean tissue. This downregulation of MIR4642 has been shown to contribute to the development of obesity. MIR4642 has also been shown to be involved in the regulation of nutrient metabolism, which is critical for weight gain and obesity.

In addition to its role in energy metabolism and nutrient metabolism, MIR4642 has also been shown to play a role in the regulation of gene expression. Studies have shown that MIR4642 can interact with several key genes that are involved in obesity, including PPAR未, PPAR未-targeted genes, and fat-promoting genes. This suggests that MIR4642 may be a useful biomarker for assessing the efficacy of drugs that target obesity.

MIR4642 has also been shown to be involved in the regulation of body composition. Studies have shown that MIR4642 can influence the expression of genes involved in bone formation and muscle development, which can contribute to body composition. Therefore, MIR4642 may be a useful biomarker for assessing the effectiveness of drugs that target obesity.

In conclusion, MIR4642 is a potential drug target and biomarker for obesity. Its role in energy metabolism, nutrient metabolism, gene expression, and body composition make it an attractive target for researchers and clinicians who are working to develop effective treatments for obesity. Further studies are needed to fully understand the role of MIR4642 in obesity and to develop effective treatments.

Protein Name: MicroRNA 4642

More Common Targets

MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747